Form 4: Trevi Therapeutics Executive Exercises Options and Sells Shares to Cover Costs
SEC Form 4 Filing
Thomas Sciascia, Chief Scientific Officer of Trevi Therapeutics, exercised stock options and sold shares to cover the exercise cost and tax obligations on May 29, 2024.
Summary
- Thomas Sciascia, the Chief Scientific Officer of Trevi Therapeutics, exercised stock options to purchase 59,354 shares of common stock at a price of $2.19 on May 29, 2024.
- Simultaneously, Sciascia sold 53,368 shares at a weighted average price of $2.5504, with individual sales ranging from $2.55 to $2.56, to cover the cost of exercising the options and to meet tax withholding obligations.
- Following these transactions, Sciascia directly owns 214,433 shares of Trevi Therapeutics common stock, which includes 14,723 shares purchased through the company's employee stock purchase plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects a routine transaction. The executive is exercising vested options and selling shares to cover costs, which doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common occurrences in publicly traded companies. Investors often monitor these filings to gauge executive sentiment and potential future actions.
Key Dates
| Date | Description |
|---|---|
| July 2, 2014 | Date the stock option was granted. |
| June 11, 2015 | 25% of the shares underlying the option vested. |
| June 11, 2018 | Remaining 75% of the shares vested in equal monthly installments. |
| May 29, 2024 | Date of stock option exercise and share sale. |
| May 31, 2024 | Date of Form 4 filing. |
| July 1, 2024 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.